
Brian N. Vinson
Examiner (ID: 1815, Phone: (571)272-2614 , Office: P/2913 )
| Most Active Art Unit | 2911 |
| Art Unit(s) | 2911, 2913, 2900, 2901 |
| Total Applications | 12036 |
| Issued Applications | 11911 |
| Pending Applications | 2 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18270229
[patent_doc_number] => 20230091471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/673703
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673703 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | Feb 15, 2022 | Abandoned |
Array
(
[id] => 18202402
[patent_doc_number] => 11584784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Systems and methods for manufacturing a silk fibroin solution and powders containing silk fibroin
[patent_app_type] => utility
[patent_app_number] => 17/650570
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 21764
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650570
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650570 | Systems and methods for manufacturing a silk fibroin solution and powders containing silk fibroin | Feb 9, 2022 | Issued |
Array
(
[id] => 17627274
[patent_doc_number] => 20220162289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/667330
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667330 | Anti-VEGF protein compositions and methods for producing the same | Feb 7, 2022 | Issued |
Array
(
[id] => 17805990
[patent_doc_number] => 20220257825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => USE OF SELF-ASSEMBLING POLYPEPTIDES AS TISSUE ADHESIVES
[patent_app_type] => utility
[patent_app_number] => 17/665947
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665947 | Use of self-assembling polypeptides as tissue adhesives | Feb 6, 2022 | Issued |
Array
(
[id] => 17655510
[patent_doc_number] => 20220175975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => HER3 Peptides for Imaging and Radiotherapy
[patent_app_type] => utility
[patent_app_number] => 17/562861
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562861 | HER3 peptides for imaging and radiotherapy | Dec 26, 2021 | Issued |
Array
(
[id] => 17655415
[patent_doc_number] => 20220175880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => CHLORIDE SALT OF TAT-NR2B9C
[patent_app_type] => utility
[patent_app_number] => 17/545995
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545995 | Chloride salt of TAT-NR2B9C | Dec 7, 2021 | Issued |
Array
(
[id] => 17790386
[patent_doc_number] => 20220249477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/545217
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545217 | Methods and compositions for treating viral or virally-induced conditions | Dec 7, 2021 | Issued |
Array
(
[id] => 17480712
[patent_doc_number] => 20220088216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/540549
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/540549 | Virus-like particle conjugates for diagnosis and treatment of tumors | Dec 1, 2021 | Issued |
Array
(
[id] => 17702837
[patent_doc_number] => 20220202843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHODS OF TREATMENT FOR BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/541019
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541019
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541019 | METHODS OF TREATMENT FOR BACTERIAL INFECTIONS | Dec 1, 2021 | Abandoned |
Array
(
[id] => 18777857
[patent_doc_number] => 11819533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Compositions and methods for the treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 17/539727
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 27
[patent_no_of_words] => 12283
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/539727 | Compositions and methods for the treatment of fungal infections | Nov 30, 2021 | Issued |
Array
(
[id] => 17881205
[patent_doc_number] => 20220296682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => CNP PRODRUGS WITH LARGE CARRIER MOIETIES
[patent_app_type] => utility
[patent_app_number] => 17/526481
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/526481 | CNP PRODRUGS WITH LARGE CARRIER MOIETIES | Nov 14, 2021 | Abandoned |
Array
(
[id] => 17720434
[patent_doc_number] => 20220213154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => AGENTS MODULATING BETA-CATENIN FUNCTIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/518247
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/518247 | Agents modulating beta-catenin functions and methods thereof | Nov 2, 2021 | Issued |
Array
(
[id] => 17850552
[patent_doc_number] => 20220280593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
[patent_app_type] => utility
[patent_app_number] => 17/514469
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17514469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/514469 | METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE | Oct 28, 2021 | Abandoned |
Array
(
[id] => 17905529
[patent_doc_number] => 11459373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Anti-VEGF protein compositions and methods for producing the same
[patent_app_type] => utility
[patent_app_number] => 17/500735
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 67535
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500735 | Anti-VEGF protein compositions and methods for producing the same | Oct 12, 2021 | Issued |
Array
(
[id] => 17505137
[patent_doc_number] => 20220098239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/499859
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499859 | Inhibition of pulmonary fibrosis with nutlin-3A and peptides | Oct 11, 2021 | Issued |
Array
(
[id] => 18374422
[patent_doc_number] => 20230149501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METHODS FOR REDUCING OXIDATIVE DAMAGE
[patent_app_type] => utility
[patent_app_number] => 17/493551
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493551
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493551 | METHODS FOR REDUCING OXIDATIVE DAMAGE | Oct 3, 2021 | Abandoned |
Array
(
[id] => 17343668
[patent_doc_number] => 20220009999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/489495
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489495 | Anti-VEGF protein compositions and methods for producing the same | Sep 28, 2021 | Issued |
Array
(
[id] => 19423769
[patent_doc_number] => 12083160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Polypeptides binding to human complement C5
[patent_app_type] => utility
[patent_app_number] => 17/479101
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 23177
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479101 | Polypeptides binding to human complement C5 | Sep 19, 2021 | Issued |
Array
(
[id] => 17314460
[patent_doc_number] => 20210403508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/478027
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478027 | Ultra-pure agonists of guanylate cyclase C, method of making and using same | Sep 16, 2021 | Issued |
Array
(
[id] => 17342209
[patent_doc_number] => 20220008540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
[patent_app_type] => utility
[patent_app_number] => 17/474114
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474114 | METHODS OF TREATING OR PREVENTING STENT THROMBOSIS | Sep 13, 2021 | Abandoned |